INTRODUCTION: We hypothesized that, like apolipoprotein E (APOE), other late-onset Alzheimer’s disease (LOAD) genetic susceptibility loci predict mortality.METHODS: We used a weighted genetic risk score (GRS) from 21 non-APOELOAD risk variants to predict survival in the Adult Changes in Thought and the Health and Retirement Studies. We meta-analyzed hazard ratios and examined models adjusted for cognitive performance or limited to participants with dementia. For replication, we assessed the GRS-longevity association in the Cohorts for Heart and Aging Research in Genomic Epidemiology, comparing cases surviving to age ≥90 years with controls who died between ages 55 and 80 years.RESULTS: Higher GRS predicted mortality (hazard ratio = 1.05; 95% confidence interval: 1.00-1.10,P = .04). After adjusting for cognitive performance or restricting to participants with dementia, the relationship was attenuated and no longer significant. In case-control analysis, the GRS was associated with reduced longevity (odds ratio = 0.64; 95% confidence interval: 0.41-1.00,P = .05).DISCUSSION: Non-APOELOAD susceptibility loci confer risk for mortality, likely through effects on dementia incidence.
Alzheimer’s disease genetic risk variants beyondAPOEε4 predict mortality
Authors: Mez, Jesse J; Marden, Jessica R JR; Mukherjee, Shubhabrata S; Walter, Stefan S; Gibbons, Laura E LE; Gross, Alden L AL; Zahodne, Laura B LB; Gilsanz, Paola P; Brewster, Paul P; Nho, Kwangsik K; Crane, Paul K PK; Larson, Eric B EB; Glymour, M Maria MM
Alzheimer's & dementia (Amsterdam, Netherlands). 2017 Mar ;8():188-195. Epub 2017-08-14.